These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 10545276)
1. Expression and characterization of glycolipid-anchored B7-1 (CD80) from baculovirus-infected insect cells: protein transfer onto tumor cells. Nagarajan S; Selvaraj P Protein Expr Purif; 1999 Nov; 17(2):273-81. PubMed ID: 10545276 [TBL] [Abstract][Full Text] [Related]
2. Protein transfer of glycosyl-phosphatidylinositol-B7-1 into tumor cell membranes: a novel approach to tumor immunotherapy. McHugh RS; Nagarajan S; Wang YC; Sell KW; Selvaraj P Cancer Res; 1999 May; 59(10):2433-7. PubMed ID: 10344754 [TBL] [Abstract][Full Text] [Related]
3. B7-1-HSA (CD80-CD24), a recombinant hybrid costimulatory molecule retains ligand binding and costimulatory functions. Wang YC; Sashidharamurthy R; Nagarajan S; Selvaraj P Immunol Lett; 2006 Jun; 105(2):185-92. PubMed ID: 16621031 [TBL] [Abstract][Full Text] [Related]
4. Modified cell ELISA to determine the solubilization of cell surface proteins: Applications in GPI-anchored protein purification. Bumgarner GW; Zampell JC; Nagarajan S; Poloso NJ; Dorn AS; D'Souza MJ; Selvaraj P J Biochem Biophys Methods; 2005 Aug; 64(2):99-109. PubMed ID: 16000225 [TBL] [Abstract][Full Text] [Related]
5. Human tumor membrane vesicles modified to express glycolipid-anchored IL-12 by protein transfer induce T cell proliferation in vitro: a potential approach for local delivery of cytokines during vaccination. Nagarajan S; Selvaraj P Vaccine; 2006 Mar; 24(13):2264-74. PubMed ID: 16376465 [TBL] [Abstract][Full Text] [Related]
6. Preparation of murine B7.1-glycosylphosphatidylinositol and transmembrane-anchored staphylococcal enterotoxin. A dual-anchored tumor cell vaccine and its antitumor effect. Yi P; Yu H; Ma W; Wang Q; Minev BR Cancer; 2005 Apr; 103(7):1519-28. PubMed ID: 15739200 [TBL] [Abstract][Full Text] [Related]
8. Surface engineering of microparticles by novel protein transfer for targeted antigen/drug delivery. Bumgarner GW; Shashidharamurthy R; Nagarajan S; D'Souza MJ; Selvaraj P J Control Release; 2009 Jul; 137(2):90-7. PubMed ID: 19328830 [TBL] [Abstract][Full Text] [Related]
9. Glycolipid-anchored IL-12 expressed on tumor cell surface induces antitumor immune response. Nagarajan S; Selvaraj P Cancer Res; 2002 May; 62(10):2869-74. PubMed ID: 12019166 [TBL] [Abstract][Full Text] [Related]
10. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2. Biburger M; Weth R; Wels WS J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482 [TBL] [Abstract][Full Text] [Related]
11. The infection of human dendritic cells with recombinant avipox vectors expressing a costimulatory molecule transgene (CD80) to enhance the activation of antigen-specific cytolytic T cells. Tsang KY; Zhu M; Even J; Gulley J; Arlen P; Schlom J Cancer Res; 2001 Oct; 61(20):7568-76. PubMed ID: 11606396 [TBL] [Abstract][Full Text] [Related]
12. Autocrine costimulation: tumor-specific CD28-mediated costimulation of T cells by in situ production of a bifunctional B7-anti-CEA diabody fusion protein. Blanco B; Holliger P; Alvarez-Vallina L Cancer Gene Ther; 2002 Mar; 9(3):275-81. PubMed ID: 11896444 [TBL] [Abstract][Full Text] [Related]
13. A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity. Chakrabarti R; Zhou ZF; Chang Y; Prud'homme GJ Vaccine; 2005 Aug; 23(37):4553-64. PubMed ID: 15919138 [TBL] [Abstract][Full Text] [Related]
14. Expression of cell surface GPI-anchored human p97 in baculovirus-infected insect cells. Kennard ML; Shimizu KY; Gabathuler R; Rothenberger S; Theilmann D; Jefferies WA Biotechnol Bioeng; 1997 Jul; 55(1):41-53. PubMed ID: 18636443 [TBL] [Abstract][Full Text] [Related]
16. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity. Todo T; Martuza RL; Dallman MJ; Rabkin SD Cancer Res; 2001 Jan; 61(1):153-61. PubMed ID: 11196154 [TBL] [Abstract][Full Text] [Related]
17. Construction and characterization of bispecific costimulatory molecules containing a minimized CD86 (B7-2) domain and single-chain antibody fragments for tumor targeting. Rohrbach F; Gerstmayer B; Biburger M; Wels W Clin Cancer Res; 2000 Nov; 6(11):4314-22. PubMed ID: 11106249 [TBL] [Abstract][Full Text] [Related]
18. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells. Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772 [TBL] [Abstract][Full Text] [Related]
19. A B7.1-antibody fusion protein retains antibody specificity and ability to activate via the T cell costimulatory pathway. Challita-Eid PM; Penichet ML; Shin SU; Poles T; Mosammaparast N; Mahmood K; Slamon DJ; Morrison SL; Rosenblatt JD J Immunol; 1998 Apr; 160(7):3419-26. PubMed ID: 9531302 [TBL] [Abstract][Full Text] [Related]
20. Time courses of B7 family molecules expressed on activated T-cells and their biological significance. Sun ZW; Qiu YH; Shi YJ; Tao R; Chen J; Ge Y; Hu YM; Ma HB; Shi Q; Zhang XG Cell Immunol; 2005; 236(1-2):146-53. PubMed ID: 16165113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]